Literature DB >> 9338624

Serum levels of cytokines after bone marrow transplantation: increased IL-8 levels during severe veno-occlusive disease of the liver.

M Remberger1, O Ringdén.   

Abstract

We investigated the cytokine profile and peak levels of interleukin (IL) -6, IL-8, IL-10 and tumour necrosis factor (TNF) -alpha levels in 42 patients after allogeneic bone marrow transplantation (BMT). Eleven of them developed veno-occlusive disease (VOD) of the liver. Fourteen patients had moderate-to-severe acute graft-versus-host disease (aGvHD), 10 isolated bacteraemia and 7 had no major complication. Those who developed severe VOD (n=6) showed a short, very high IL-8 peak (median: 6632 pg/ml, range: 5546-10,000 vs. 280 pg/ml, 0-2042 in controls, p<0.01) 1-4 d after diagnosis of the liver disease. Five of these patients had high peak levels of IL-6. Five patients with mild VOD showed a lower increase in the cytokines tested. Bilirubin levels, at day of IL-8 peak, did not differ statistically between mild and severe VOD. The highest levels of IL-10 were found in those with aGvHD. IL-8 levels were also increased, but not to the same extent as in patients with severe VOD (p=0.01 vs. VOD). In patients with bacteraemia, very high levels of IL-6 were seen. In patients without major complications, the levels of cytokines were low. In conclusion, high levels of IL-8 occurred in severe VOD of the liver, which may be of value to determine prognosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9338624     DOI: 10.1111/j.1600-0609.1997.tb00985.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  8 in total

1.  Cytokine levels following allogeneic hematopoietic cell transplantation: a match-pair analysis of home care versus hospital care.

Authors:  Olle Ringdén; Mats Remberger; Johan Törlén; Sigrun Finnbogadottir; Britt-Marie Svahn; Behnam Sadeghi
Journal:  Int J Hematol       Date:  2021-02-05       Impact factor: 2.490

2.  Variable incidence of cyclosporine and FK-506 neurotoxicity in hematopoeitic malignancies and marrow conditions after allogeneic bone marrow transplantation.

Authors:  Walter S Bartynski; Zella R Zeigler; Richard K Shadduck; John Lister
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

3.  Interleukin-7 receptor-alpha gene polymorphisms in bone marrow transplant recipients.

Authors:  Negar Azarpira; Mehdi Dehghani; Mahdokth H Aghdaie; Masumeh Darai
Journal:  Mol Biol Rep       Date:  2009-03-01       Impact factor: 2.316

4.  Cytokine serum levels during post-transplant adverse events in 61 pediatric patients after hematopoietic stem cell transplantation.

Authors:  Michaela Döring; Karin Melanie Cabanillas Stanchi; Markus Mezger; Annika Erbacher; Judith Feucht; Matthias Pfeiffer; Peter Lang; Rupert Handgretinger; Ingo Müller
Journal:  BMC Cancer       Date:  2015-08-28       Impact factor: 4.430

5.  Pathogenesis of FOLFOX induced sinusoidal obstruction syndrome in a murine chemotherapy model.

Authors:  S M Robinson; J Mann; A Vasilaki; J Mathers; A D Burt; F Oakley; S A White; D A Mann
Journal:  J Hepatol       Date:  2013-04-23       Impact factor: 25.083

6.  The potential contribution of tumour-related factors to the development of FOLFOX-induced sinusoidal obstruction syndrome.

Authors:  S M Robinson; D A Mann; D M Manas; F Oakley; J Mann; S A White
Journal:  Br J Cancer       Date:  2013-10-10       Impact factor: 7.640

7.  COVID-19-induced endotheliitis: emerging evidence and possible therapeutic strategies.

Authors:  Eleonora Calabretta; Jose M Moraleda; Massimo Iacobelli; Ruben Jara; Israel Vlodavsky; Peter O'Gorman; Antonio Pagliuca; Clifton Mo; Rebecca M Baron; Alessio Aghemo; Robert Soiffer; Jawed Fareed; Carmelo Carlo-Stella; Paul Richardson
Journal:  Br J Haematol       Date:  2021-02-04       Impact factor: 6.998

Review 8.  Role of Biomarkers as Predictors of Infection and Death in Neutropenic Febrile Patients after Hematopoietic Stem Cell Transplantation.

Authors:  Karin Massaro; Silvia Figueiredo Costa
Journal:  Mediterr J Hematol Infect Dis       Date:  2015-10-15       Impact factor: 2.576

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.